Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Vehicle Controlled, Efficacy and Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

NCT03028363 is registered in ClinicalTrials.gov with Dermira, Inc. as lead sponsor.

NCT NCT03028363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03028363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Vehicle Controlled, Efficacy and Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Lead sponsor
Dermira, Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 27, 2016
Completion date
November 28, 2017
Enrollment
759 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris